Cancer treatment comprising a histone deacetylase inhibitor...

Details Cancer treatment comprising a histone deacetylase inhibitor... Cancer treatment comprising a histone deacetylase inhibitor...

A - Human Necessities

61

K

A61K 31/4406 (2006.01) A61K 31/282 (2006.01) A61K 31/337 (2006.01) A61K 31/4745 (2006.01) A61K 31/475 (2006.01) A61K 31/513 (2006.01) A61K 31/555 (2006.01) A61K 31/70 (2006.01) A61K 31/704 (2006.01) A61K 31/7068 (2006.01) A61K 33/24 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2527191

An anticancer drug having a synergistic effect by combined use of a histone acetylase derivative such as N-(2-aminophenyl)-4-[N-(pyridin-3- ylmethoxycarbonyl) aminomethyl]benzamide (MS-275) and another anticancer active substance.

L'invention concerne un médicament anticancéreux présentant un effet synergétique grâce à l'utilisation combinée d'un dérivé d'histone acétylase tel N-(2-aminophenyl)-4-[N-(pyridine-3-ylmethoxycarbonyl) aminomethyl]benzamide (MS-275) et d'une autre substance active anticancéreuse.

Affiliated with

Also associated with

Rating

Cancer treatment comprising a histone deacetylase inhibitor... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cancer treatment comprising a histone deacetylase inhibitor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cancer treatment comprising a histone deacetylase inhibitor... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1675981